Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-05

FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Edenbridge Pharmaceuticals LLC.)

View source ↗

Summary

FDA approved a supplemental application for pantoprazole sodium from Edenbridge Pharmaceuticals LLC., indicating an approved modification under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pantoprazole sodium (pantoprazole sodium)

Snippet

SUPPL AP for PANTOPRAZOLE SODIUM (PANTOPRAZOLE SODIUM)